Fingerprint
Dive into the research topics of 'Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer
Mimi I. Hu, Rossella Elisei, Marek Dedecjus, Aron Popovtzer, Maralyn Druce, Ellen Kapiteijn, Furio Pacini, Laura Locati, Jolanta Krajewska, Richard Weiss, Robert F. Gagel
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations